Apollo Hospitals has introduced ‘Cerament G’, a new injectable treatment aimed at managing severe bone infections and supporting bone regeneration. Developed by Bone Support AB, the technology is designed especially for patients dealing with complex orthopedic conditions, including diabetic foot complications and trauma-related bone damage.
Cerament G works as an antibiotic-releasing synthetic bone graft substitute, helping control infection at the affected site while simultaneously supporting bone healing. The treatment offers an alternative to conventional bone grafting procedures and is expected to improve recovery outcomes in difficult orthopedic cases.
According to the hospital, the solution could help lower the risk of amputations, reduce the need for repeated surgeries, and shorten hospitalisation periods for patients with chronic bone infections and diabetic foot problems.
“For patients, this means not just faster healing, but the ability to retain mobility, independence, and dignity,” said Dr Sangita Reddy.
As part of the launch, Apollo Hospitals organised advanced clinical training sessions for medical professionals, including cadaveric workshops and live surgical demonstrations conducted by senior orthopedic specialists. The initiative aims to enhance clinical expertise and improve long-term patient mobility and quality of life.
The launch of Cerament G reflects the growing adoption of advanced regenerative technologies in orthopedic care. By combining infection control with bone healing, the treatment could offer new hope to patients facing serious bone complications and help improve recovery outcomes in complex cases.